Effect of Bronchodilatator Testing on Multiple-breath-washout (MBW) Derived Lung Function Parameters

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02826226

Enrollment

145

Registered

2016-07-07

Start date

2016-05-31

Completion date

2018-12-31

Last updated

2019-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Ventilation Disorders

Brief summary

The investigators aim to evaluate the effect of bronchodilatator testing on multiple-breath-washout derived lung function parameters.

Interventions

DEVICEmultiple-breath-washout test

DRUGBronchodilator Agents

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* known or suspected obstructive ventilation disorder * clinical indication for bronchodilator testing

Exclusion criteria

* pregnancy * inability to participate

Design outcomes

Primary

Measure	Time frame
change of lung clearance index (LCI) as determined by multiple breath washout	60 minutes

Secondary

Measure	Time frame
repeatability of lung clearance index (LCI)	60 minutes

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026